2022 American Transplant Congress Archives - Page 38 of 190

Daratumumab for Recurrence of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits in a Post-Kidney Transplant Recipient: A Case Report

K. Progar¹, T. Alhamad², H. Murad³, A. Java⁴, A. Malone⁵, J. Gaut⁶, R. Delos Santos⁷, M. Merzkani⁸
Daratumumab Therapy Achieves Dialysis Independence in Kidney Transplant Recipients with Resistant Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits

P. Yenebere, R. Daloul
Data-Driven Clustering Distinguishes Infection from Rejection During Hospital Admissions Following Pediatric Lung Transplantation

C. D. Britto¹, D. Boyer², G. Visner³, G. Priebe⁴, L. Midyat³
DCD and AKI Kidneys Experiencing DGF as a Platform for the Study of Adaptive Repair

B. Bussolati¹, S. Da Sacco², A. Asthana³, L. N. Byers³, L. Perin⁴, M. S. Garner³, B. Sharda³, A. C. Farney³, C. J. Jay³, R. J. Stratta³, S. J. Walker⁵, G. Orlando³
DCD Liver Grafts Can Safely be Used for Recipients with Grade 1-2 Portal Vein Thrombosis

L. A. Mercado¹, H. K. Bhangu¹, K. R. Musto², K. D. Watt³, B. Taner⁴, C. B. Rosen⁵, T. Taner⁵, L. Yang¹, D. M. Harnois¹, J. D. LeGout⁶, K. P. Croome⁴
DCD vs DBD Pancreas Transplant Outcome – A Comprehensive Registry Analysis

A. C. Gruessner¹, S. J. Saggi², R. Gruessner¹
Dd-cfdna Correlates With Acute Rejection In The Setting Of Bk Viremia After Kidney Transplantation

N. M. Ali¹, J. Miles², V. Tatapudi¹, R. Chand¹, R. Montgomery¹
dd-cfDNA Varies Among Diagnostics Groups of Pulmonary AMR

D. Levine¹, C. Giner¹, C. Pham², R. Woodward³, A. Roux⁴
De Novo Anti-Brush Border Antibody Disease in a Kidney Transplant Recipient

P. Yenebere, D. Ibrahim, T. Nadasdy, R. Daloul
De Novo Donor-Specific Antibody Development in Heart Transplant Recipients Following COVID-19 Vaccination

M. Cheng¹, O. Behbahani-Nejad¹, D. Gupta²
De Novo Donor-Specific Antibody Development with Mycophenolate versus Azathioprine in Lung Transplant Recipients

A. Prom¹, K. Walter², K. Gomez³, C. Doligalski¹, L. Lobo¹, R. Evans¹
De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding

R. J. Knight, E. A. Graviss, D. T. Nguyen, T. N. Eagar, S. G. Yi, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber
De Novo Fibrinogen Alpha Chain Amyloidosis in Kidney Allograft

T. Khaja¹, L. Truong², G. Nassar¹
De Novo Focal Segmental Glomerulosclerosis in the Kidney Allograft: Association with Alloimmunity Leading to Poor Outcome

J. Leon¹, J. Duong Van Huyen², A. Abderrahmane¹, D. Anglicheau¹, C. Legendre¹, M. Rabant²
De Novo Lipoprotein-X Causing Hypercholesterolemia and Acute Kidney Injury (AKI) in Simultaneous Liver Kidney Transplant (SLKT) Patient

H. Me, S. S. Nair, M. Al-Qaisi, M. Ryan, L. Kodali, B. Aqel
De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation

G. Petrossian¹, J. Ortiz², K. Addonizio¹, A. Hsiao¹, L. Teixeira¹, N. Koizumi³, R. James³, S. Patel⁴, D. Conti², R. Plews²
De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients

G. Petrossian¹, J. Ortiz², K. Addonizio¹, L. Teixeira¹, A. Hsiao¹, R. James³, N. Koizumi³, S. Patel⁴, D. Conti², R. Plews²
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs

S. Iskhagi¹, R. Shahbazov¹, A. Ball¹, S. Loerzel¹, E. Shaban², B. Gallay², R. Hod Dvorai³, J. Leggat², M. Hanlon¹, R. Saidi¹
Deceased Donor Organ Flush with Similar Volumes of HTK and UW at a Single U.S. Organ Procurement Organization: Adult and Pediatric Data

A. E. Mangus¹, C. Kubal², B. Ekser³, P. Mihaylov⁴, A. J. Lutz¹, J. Fridell⁵, R. Mangus⁶
Deceased Donor Procurement Biopsy Practices, Interpretation, and Histology-Based Decision Making: A Survey of US Transplant Centers

V. Fleetwood¹, D. Axelrod², Y. Caliskan¹, H. Randall¹, J. Wellen³, M. Lichtenberger³, C. Dedert¹, R. Rothweiler⁴, G. F. Marklin⁴, D. Brockmeier⁴, M. A. Schnitzler¹, S. A. Husain⁵, S. Mohan⁵, B. Kasiske⁶, M. Cooper⁷, K. L. Lentine¹
Deceased Donor Vein Extension Grafts for Right Living-Donor Kidney Transplantation

A. Meinders, S. G. Yi, M. Hobeika, R. McMillan, H. Podder, A. Gaber, R. J. Knight
Decellularized Human Pancreatic Extracellular Matrix-Based Physiomimetic Microenvironment for Human Islet Culture

A. Asthana¹, D. Chaimov¹, R. Tamburrini², S. J. Walker³, G. Orlando¹
Decision-Making Among HCV-Negative Transplant Candidates Offered Organs from Donors with HCV Infection

E. Schnellinger¹, E. Saine¹, M. Liu¹, J. Diamond¹, M. Crespo¹, S. Prenner¹, V. Potluri¹, C. Bermudez¹, H. Mentch¹, M. Moore², B. Besharatian¹, D. Goldberg³, F. Barg¹, P. Reese¹
Decreased Mortality from Sars-CoV-2 Infection in Kidney Transplant Recipients Over the Course of the Pandemic

Y. Al Azzi, P. Loarte, C. Pynadath, L. Liriano, M. Ajaimy, S. Kapoor, H. Yaffe, M. Le, J. Graham, J. Rocca, S. Greenstein, M. Kinkhabwala, E. Akalin
Deep Learning Identifies Arterial Intimal Fibrosis in Kidney Transplant Biopsies

K. Liu¹, Z. Yi², S. Ward³, F. Salem³, W. Zhang²
Deep Phenotyping Methods Highlight Recipient-Derived CD16+ NK and CD16+ Monocyte Infiltration During Kidney Transplant Rejection

B. Lamarthée¹, J. Callemeyn¹, P. Koshy², T. Debyser³, E. Van Loon¹, A. Franken⁴, T. Van Brussel⁴, I. Arijs⁴, D. Lambrechts⁴, A. Senev¹, T. Vaulet⁵, C. Tinel¹, M. Naesens¹
Deep-Learning Based Pathological Assessment of Frozen Procurement Kidney Biopsies

Z. Yi¹, C. Xi¹, M. Menon², P. Cravedi¹, B. Murphy¹, S. Ward¹, F. Salem¹, W. Zhang¹
Defatting of Steatotic Liver Grafts by Normothermic Ex Vivo Liver Machine Perfusion with 2,4 Dinitrophenol

J. M. Gassner¹, J. Michelotto¹, S. Moosburner¹, F. Strobl¹, A. L. Birkenfeld², A. Kurzbach², G. Shulman³, X. Zhang³, M. Selzner⁴, Y. Noguchi⁴, J. Pratschke¹, I. M. Sauer¹, N. Raschzok¹
Defects in Kim-1 Do Not Result In Delayed Graft Function After Kidney Transplantation

R. S. Suri¹, J. Lee², M. Ban³, B. Shrum², O. Z. Ismail⁴, S. Leckie⁵, A. McIntyre³, Q. Xu⁶, S. H. Lee², S. de Chickera², R. A. Hegele², L. Gunaratnam²
Deficiency of Antibody-Suppressor CXCR5⁺CD8⁺ TCells (Not CD4⁺ T_regs) Drive High Alloantibody Production in CCR5 KO Kidney Transplant Recipients

J. L. Han¹, J. M. Zimmerer¹, Q. Zeng², S. Chaudhari¹, C. K. Breuer², G. L. Bumgardner¹
Defining New Arterial and Arteriolar Lesions Accompanying Transplant Glomerulopathy: Potential Additions to the Histologic Assessment of ABMR

A. Perkowska-Ptasinska¹, D. Deborska-Materkowska², M. Ciszek³, M. Myslak⁴, J. Chang⁵, J. Reeve⁶, P. Halloran⁷
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Pre-Transplant Elevated Plasma Oxalate Levels

D. Khan, N. Zhang, M. Keddis
Defining the Longitudinal Dynamics of Immune Cells in Blood in the First Year After Pediatric Liver Transplantation (pLTx)

E. Chichelnitskiy¹, L. Ruhl², I. Goldschmidt³, A. Karch⁴, L. Antiga⁵, D. Debray⁶, L. Hierro⁷, D. Kelly⁸, V. McLin⁹, E. Nicastro¹⁰, J. Pawlowska¹¹, P. Czubkowski¹¹, R. Mikolajczyk¹², U. Baumann¹³, C. Falk¹⁴
Degree of Pre-Liver Transplant Immune Dysfunction Correlates with Post-Transplant Cancer Recurrence

G. S. Prakash¹, G. G. Panayotova¹, S. Simonishvili¹, Y. Qin¹, L. Jin¹, T. Ayorinde¹, L. J. Minze², F. Paterno¹, L. Brown¹, A. Amin¹, D. Liu¹, R. Ghobrial², J. V. Guarrera¹, K. E. Lunsford¹
Delayed Graft Function in Kidney Transplant Recipients is Associated with an Increased Risk f Post-Transplant Infections

V. Manchala, B. Muth, E. Yousif, J. Turk, J. Blazel, M. Bloom, N. Garg, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot, B. Astor, S. Parajuli
Delayed Graft Function in Living Donor Kidney Transplantation: Risk Factors and Outcomes

G. Defelice¹, A. Paramesh², H. Jeon², K. Atiemo², M. Killackey², A. Vijay²
Deletion of AIF-1 Promotes Kidney Reparative Macrophages and Prevents Fibrosis

I. Husain, A. Dangi, X. Luo
Deletion of Fibroblastic Reticular Cell Derived Laminin A4 Impairs Lymph Node Vasculature and Conduits

L. Li¹, M. Shirkey¹, W. Piao¹, A. Kensiski¹, V. Saxena¹, T. Zhang¹, X. Li², J. Zhao², S. Gavzy¹, R. Abdi², J. Bromberg¹
Delivery of Extracellular Matrix Targeted Regulatory T Cells by Novel Nanofiber Coatings for Transplantation Therapies

L. Gallon¹, J. K. Carrow², J. He¹, Y. Sambandam¹, X. Lai¹, J. Mathew¹, L. C. Palmer², J. R. Leventhal¹, Z. Zhang¹, S. I. Stupp²
Delivery of Plasmin During Machine Perfusion or Cold Storage Flush Improves Early Transplant Outcomes in aRat Dcd Liver Transplant Model

N. Abraham¹, M. Zhang¹, P. Cray², R. Neill¹, G. Cywinska¹, J. Migaly¹, R. Kahan¹, A. Pontula¹, J. Penaflor¹, Q. Gao¹, K. P. Samy¹, J. J. Pollara², V. Novokhatny³, M. G. Hartwig¹, A. S. Barbas¹
Delta Changes in Donor-Derived Cell-Free DNA (dd-cfDNA) Complement the Donor Fraction in Kidney Transplant Surveillance

A. Wiseman¹, M. Jagadeesan², G. Gupta³, V. Rao⁴, M. Narayanan⁵, N. Agrawal⁶, G. Shekhtman⁶, Y. Fu⁶, K. Pinney⁶, S. Anand⁷
Demographic Characteristics of VCA Candidates and Recipients in the U.S.

J. Wainright¹, L. Cartwright¹, A. Henderson¹, W. Cherikh¹, S. Booker¹, D. Klassen²
Dendritic Cell Senescence as a Key Contributor to Transplant Rejection

J. Zhao¹, X. Li¹, S. Jung¹, H. Zhang¹, V. Kasinath¹, J. Azzi¹, P. Sage¹, J. Bromberg², R. Abdi¹
Depletion of Donor Macrophages Permits Post-Transplant Tolerance Induction

M. Dilts¹, A. Dangi², X. Luo³
DEPTOR: A Novel Endothelial-Specific Regulator of Cell-Intrinsic Anti-Inflammation Following Transplantation

C. Testini¹, S. Bose¹, K. Liu¹, S. Kong¹, E. Flynn¹, M. Miovski¹, J. Leyva-Rangel¹, M. Laplante², J. Wedel¹, D. M. Briscoe¹
Derivation of a Cardiac Risk Index for Use in Liver Transplantation for Non-Alcoholic Steatohepatitis

P. Levy, C. Harrington, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner
Desensitization Protocol Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab in Highly Sensitized Kidney Transplant Recipients

M. Okada, T. Hiramitsu, T. Tomosugi, K. Futamura, S. Narumi, N. Goto, Y. Watarai
Desensitization Protocol to Prevent Severe Oliguric Antibody-Mediated Rejection

H. Ishida¹, K. Unagami¹, T. Kamzawa¹, K. Omoto¹, H. Shimizu¹, K. Tanabe²
Desensitization Using Costimulatory Blockade and Bortezomib to Prevent DSA Formation and Rejection in Reconstructive Transplantation

B. Oh, F. Messner, Y. Guo, G. Brandacher
Designing Continuous Distribution for Liver Allocation

M. Mankowski¹, N. Wood², D. Segev³, S. Gentry²
Detection of Alloreactive CD8+ T Cell Responses and the Immunopeptidome That Elicits Their Activation

A. B. Morris, X. Zhang, E. V. Peek, A. Hadley, C. Larsen
Detection of CMV Mediated Sub-Clinical Rejection by Urine Biomarkers

S. Ghosh¹, R. Sarwal¹, C. Mark¹, E. Reed², J. Shoji³, S. Bunnapradist², T. Sigdel³, M. Sarwal³
Detection of Early Graft Injury After Liver Transplantation with Blood-Bile Ratio of Tacrolimus: The TUBE Trial

M. M. Pascale¹, G. Bianco¹, L. Ferri¹, F. Giovinazzo¹, A. Liguori², G. Marrone², A. Grieco², S. Agnes¹
Detection of Microbiota from Catheter Tip in Hemodialysis Patients During the Perioperative Period of Kidney Transplantation Based on Metagenomics: A Prospective Study

Z. Yan, Y. Wang, W. Zeng, R. Xia, W. Deng, J. Xu, Y. Miao
Developing A Tool To Assess Psychosocial Determinants Of Health And Quality Of Life In Pediatric Liver Transplant Patients

C. R. Christmann¹, S. Rath², S. Sakhuja³, N. Galvan²
Development and Validation of a Kidney Transplant-Specific Measure of Treatment Burden

E. Lorenz¹, T. Petterson¹, I. Zaniletti¹, K. Lackore¹, B. Johnson¹, M. Mai², S. Nair³, A. Bentall¹, K. Yost¹, D. Eton¹
Development and Validation of a Machine Learning Based Virtual Biopsy System in Kidney Transplant Patients

D. Yoo¹, G. Divard¹, M. Raynaud¹, A. Bentall², M. Stegall³, M. Naesens⁴, I. Batal⁵, S. Coley⁶, J. Gill⁷, M. Mengel⁸, L. Cornell³, M. P. Alexander², T. Coates⁹, C. Legendre¹⁰, P. Reese¹¹, c. lefaucheur¹², O. Aubert¹, A. Loupy¹
Development and Validation of a Medication Safety Dashboard in Veteran Transplant Recipients: Preliminary Results of a Multicenter Cluster-Randomized Controlled Clinical Trial

D. Taber¹, R. Felkner², K. Rife³, D. Cooney³, S. Laforest³, E. Santa⁴, N. Super⁵, C. Hall⁶, T. Goddard¹, R. Alexander¹
Development and Validation of an Integrative DD-CFDNA System to Predict Allograft Rejection: A Population Based Study

O. Aubert, R. Brousse, J. Gueguen, M. Racape, C. Lefaucheur, A. Loupy
Development of a Comprehensive Banff Automation System for Kidney Allograft Precision Diagnostics

D. Yoo¹, J. Gueguen¹, G. Divard¹, M. Raynaud¹, V. Goutaudier¹, M. Rabant¹, M. Haas², M. Mengel³, O. Aubert¹, A. Loupy¹
Development of a Culturally Sensitive Chatbot to Inform Living Donor Candidates of African Ancestry About Apol1 Genetic Testing

E. J. Gordon¹, P. Waite², J. Gacki-Smith², D. Duquette³, A. Agrawal¹, J. Friedewald¹, S. Savage⁴, E. Simmons⁵, M. Cooper⁶, A. Gilbert⁶, C. Wicklund⁷
Development of a Dynamic Map of Peripheral Myeloid Cells Associated with Acute Rejection of Vascularized Composite Tissue Allografts

J. T. Harden¹, S. E. Fuentes¹, X. Wang¹, J. Enriquez¹, A. Reitsma¹, C. 0. Esquivel², O. M. Martinez³, S. M. Krams³
Development of a Patient-Reported Outcome Measure of Neurological Side Effects from Immunosuppression in Kidney Transplant Recipients

C. Hurt¹, G. J. Greene¹, J. Friedewald², D. P. Ladner², A. Waterman³, D. Cella¹, D. Peipert¹
Development of a Portable Device to Quantify Hepatic Steatosis in Donated Livers Using an AI Algorithm

S. Klinkachorn¹, C. J. Tsoi-A-Sue², R. R. Narayan², M. L. Melcher²
Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study

F. Qazi Arisar¹, E. Salinas-Miranda², H. Ale Ali², K. Lajkosz³, C. Chen¹, A. Azhie¹, G. M. Healy², D. Deniffel², M. A. Haider², M. Bhat¹
Development of an M2 Macrophage Signature in Spontaneously Accepted Kidney Allografts

M. T. Guinn¹, E. S. Szuter¹, T. Yokose¹, J. Ge², B. Kwon¹, I. Rosales³, P. S. Russell¹, A. G. Cuenca², J. C. Madsen⁴, R. B. Colvin³, A. Alessandrini¹
Development of Diagnostic Algorithms for Peri-Operative Error Cause and Effect Analysis in Renal Transplant Surgery

P. Gogalniceanu¹, H. Maple¹, G. Papadakis¹, P. Chandak¹, I. Loukopoulos¹, J. Olsburgh¹, N. Kessaris¹, F. Calder¹, N. Sevdalis², N. Mamode¹
Development of Ex-Situ Hypothermic and Normothermic Reperfusion as an Innovative Method to Preserve an Assess Uterus: A Preliminary Result

L. Dion¹, E. Loiseau², B. Mesnard³, G. Blancho⁴, T. Thubert⁵, J. Hervouet⁴, D. Minault⁴, S. Le Bas-Bernardet⁶, R. Josien⁶, V. Lavoué¹, J. Branchereau⁷
Development Process of Minimally Invasive Living Donor Liver Transplantation (from Pure Laparoscopic Explant Hepatectomy to Robotic Graft Implantation)

K. Suh, S. Hong, S. Lee, S. Suh, S. Hong, E. Han, Y. Choi, N. Yi, K. Lee
Diabetes is a Significant and Independent Predictor for Tacrolimus Immediate Release (IR) and LCP-Tacrolimus (LCP) Conversion Ratios

K. S. Coffman, N. Patel, F. Bartlett, J. Newman, S. Patel, T. Sprague, N. Rao, E. Andrade, M. Casey, V. Rohan, D. DuBay, D. Taber
Diabetes Mellitus and Blood Glucose Variability Increases the 30-day Readmission Rate After Kidney Transplantation

H. Chakkera¹, C. Cook¹, S. Saghafian², A. Orfanoudaki³
Diagnosis of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach

H. Iwamoto¹, O. Konno¹, Y. Kihara¹, M. Okihara¹, I. Akashi¹, T. Ueno¹, M. Sugimoto²
Diagnostic Performance of Donor-Derived Cell-Free DNA Assay (AlloSure®) in Kidney Transplant Recipients with Graft Dysfunction: A Single Center Study

M. S. Naseer¹, H. Shokouh-Amiri², T. Creamer¹, R. McMillan², S. Tandukar¹, D. Aultman¹, G. B. Zibari¹, N. Singh¹
Dialysis Patient Perspectives on Obesity as a Barrier to Kidney Transplantation

S. S. Hingorany, A. Klassen, B. Milliron, J. Sweeting, J. Lee, R. HaileSelasse, B. Gunen, M. N. Harhay
Dietary Sodium Intake And Blood Pressure In Living Kidney Donors (SPLID): Rationale And Design Of A Pilot Single-center Crossover Single-blind Randomized Controlled Trial

E. Tantisattamo¹, U. G. Reddy¹, A. J. Ferrey¹, H. Ichii², D. C. Dafoe², H. Moradi¹, C. M. Rhee¹, K. Kalantar-Zadeh¹
Differences in Acceptance to the Kidney Transplant List

J. Cotton¹, K. Perry², N. Costa³, S. Niederhaus¹
Differences in Medication Adherence Between Preemptive and Post-Dialysis Young Kidney Transplant Recipients

Y. Vaisbourd¹, E. Samson², A. De Simone², M. Dahhou², B. Foster³
Differences in Post-Liver Transplant Hospitalizations by Patient Race

K. Ross-Driscoll¹, R. Lynch¹, J. Wedd², R. Patzer¹
Differences in Strength and Longevity of SARS-CoV-2-Specific Adaptive Immunity Between Convalescent and Vaccinated SOT Patients and Immunocompetent Individuals

L. Donadeu¹, S. Gomez¹, A. Fava'², E. Crespo¹, F. Moreso³, M. Lopez³, L. Lladó⁴, J. González⁴, I. Campos³, M. Muñoz³, J. Quintero³, J. Esperalba³, O. Bestard³
Differences of Fk-Binding Protein 12 and P-Glycoprotein Explain the Differences in the Intracellular Tacrolimus Concentration of T Lymphocytes and Monocytes

S. Udomkarnjananun, C. Baan, B. de Winter, D. Hesselink
Differential Impact of Subclinical Kidney Transplant Rejection in Young Adults

S. Raza¹, G. Agarwal¹, H. Fatima¹, R. Gaston¹, V. Hauptfeld-Dolesjek¹, B. Julian¹, C. Kew¹, V. Kumar¹, S. Mehta¹, S. Ong¹, F. Rosenblum¹, G. Towns¹, R. Mannon², M. Seifert¹
Differentially Methylated Genes Predict Post-Transplant Relapse of Unresectable Hepatoblastoma

M. Ningappa¹, M. Muarya², C. Ashokkumar¹, H. Hakonarson³, S. Subramaniam⁴, R. Sindhi¹
Differing Gene Expression Profiles and Signaling Pathways Observed Between Alloreactive and Tolerant T Cells in a Recipient Following Bilateral Orthotopic Lung Transplant (BOLT) and Bone Marrow Transplant (BMT) from the Same Cadaveric UNOS Donor

P. Szabolcs, E. Garchar, D. Rajasundaram, X. Chen
Digital Spatial Profiling of Kidney Allograft Biopsies with Chronic Allograft Dysfunction in African American Transplant Recipients

C. R. Dorr¹, S. A. Elmer¹, B. Wu², B. Guo², J. Czyzyk², G. Crary³, G. Onyeaghala¹, W. Oetting², P. Jacobson², R. B. Mannon⁴, G. Agarwal⁵, J. Maltzman⁶, A. Matas², A. Israni³
Direct Central Ambulatory Venoarterial Extracorporeal Membrane Oxygenation and Double Lung Transplantation without Graft Reduction with Extreme Mediastinal Shift

A. Gorton¹, S. Keshavamurthy²
Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients

A. Rizvi¹, M. Kueht², S. Hussain³, J. Fair², R. Ramirez⁴, A. Gamilla-Crudo⁵, M. Mujtaba⁵
Direct Health Care Costs Before and After Kidney Transplantation in Germany – A Longitudinal Analysis Based on Claims Data

S. Ronicke¹, K. Budde¹, D. Schmidt², W. Düttmann¹, M. G. Naik¹, C. J. Wagner³, J. Freitag³, B. Osmanodja¹
Direct Oral Anticoagulants versus Warfarin in Adult Heart Transplant Recipients

L. Shitanishi, A. Fan, T. Khuu, R. Ardehali
Direct Procurement of Heart and Lungs from a Controlled DCD Donor with Ongoing Abdominal Normothermic Regional Perfusion (aNRP) – A Synchronized Retrieval

M. Husain¹, A. Jothidasan¹, C. Zeschky¹, M. Osman², M. Berman², R. Gaurav³, A. Butler³, C. Watson³, B. Stutchfield⁴, I. Currie⁵, G. Oniscu⁵, J. Dunning¹, U. Stock¹
Discordant Histological Findings During Acute Rejection in a Combined Face and Hand Transplant Recipient

O. C. Onuh¹, J. Trilles¹, W. J. Rifkin¹, H. Brydges¹, B. F. Chaya¹, R. Rodriguez Colon¹, D. Boczar¹, D. J. Ceradini¹, E. D. Rodriguez¹, B. E. Gelb²
Discovery of Risk Factor Control Targets Using Machine Learning and Network Analysis for One-Year Renal Allograft Dysfunction

Y. Lee¹, M. Hong², J. Kong³, O. Kwon⁴, C. Jung⁵, J. Yang⁶, M. Kim⁷, H. Han⁸, S. Nam⁹
Discrepancy Rates Between Histology (HIST) and Molecular Diagnosis (MDX) of T-cell Mediated Rejection (TCMR) Depend on Choice of Bioinformatics Pipeline

M. Ellison, D. Spagnolo, P. Randhawa
Disparities Associated with Road Travel Distance of Living Kidney Donors in the United States: An SRTR Analysis

K. Nijhar¹, A. Kernodle¹, J. D. Motter¹, K. Khoo¹, A. Massie², E. King³, D. Segev¹
Disparities in Liver Transplant Access for HCC Patients Based on Patient Blood Type and the Intensity of Competition for Organs Under MMAT-3

A. J. Ahearn, H. Chowdhry, J. L. Dodge, K. Zhou
Disparities in Liver Transplantation in Patients with HCC Diagnosis

C. Warren¹, A. Zarrinpar²
Disparities in Low Respiratory Vaccination Among Solid Organ Transplant Recipients

J. R. Felzer¹, A. M. LeMahieu², L. J. Finney Rutten², Y. Juhn³, C. Wi³, R. M. Jacobson³, C. C. Kennedy¹
Disparity In U.S. Organ Donation And Transplantation During A Global Pandemic

J. Buggs¹, K. Dhanireddy¹, A. Kumar², N. Kemmer³
Disruption of B Cell Population is Associated with Increased Infections in Pediatric Transplant Recipients

B. Geng, L. Loop, C. Anterasian, D. Mortazavi, J. Kitsen, C. Collins, K. Newton, E. Ingulli
Distinct Phenotypes of Kidney Transplant Recipients Aged 80 Years or Older in the United States by Machine Learning Consensus Clustering

S. A. Mao¹, C. Thongprayoon², M. A. Mao³, C. C. Jadlowiec⁴, N. Leeaphorn⁵, M. Cooper⁶, W. Cheungpasitporn²
Distinct Phenotypes of Kidney Transplant Recipients with Delayed Graft Function Identified Through Machine Learning Consensus Clustering

C. Jadlowiec¹, C. Thongprayoon², N. Leeaphorn³, W. Kaewput⁴, P. Pattharanitima⁵, M. Cooper⁶, W. Cheungpasitporn²
Disulfide HMGB1 Reprograms Macrophages to Induce Alloimmunity via TLR4 and TLR9 Pathways Following Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation

A. Q. Terry¹, R. A. Sosa¹, F. Kaldas², R. Busuttil³, D. Gjertson¹, J. Kupiec-Weglinski¹, E. Reed¹
Do Clinical & Pathologic Signs of Rejection Develop Following Transplantation of Tissue Containing Non-Autologous Mitochondria in an Autologous Nuclear Cloned Host?

S. Jacob¹, M. L. Baack², A. Savinov³, P. J. Wettstein⁴
Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

C. Hoopes
Do Early Trends of Donor-Derived Cell Free DNA Predict Long Term Kidney Allograft Outcomes?

S. Park¹, K. Guo², L. Zhao², C. Rebello², J. Friedewald²
Do Social Support Requirements Delay Time to Listing Decision in Liver Candidates?

M. Jesse¹, A. Peleman¹, M. Karrick¹, F. Nimri¹, N. Parikh², A. Segal¹, D. Moonka¹, M. Abouljoud¹, A. Yoshida¹
Do Videos Work Better Than Digital Ads at Reaching Audiences? Examining Which Message Types Engage and Encourage Further Exploration of Living Donation

L. A. Davis¹, A. Livingston², A. Waterman³
Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient

J. Byrns¹, G. Katz-Greenberg²
Does ABO/HLA Matching Matter in Uterus Transplantation?

L. Johannesson¹, M. Askar¹, A. Wall², G. Testa¹
Does Black Race Modify the Risk of Transplant Failure Associated with HLA Mismatch in First Adult Kidney Allografts from Deceased Donors?

K. Atiemo
Does Comprehensive Geriatric Assessment Impact Risk Assessment for Potential Kidney Transplant Patients?

J. Patel¹, S. Hussain², D. Mills¹, A. Edobor³, E. Walters³, J. Williams³, Y. Kyeso², J. F. Fung³, R. Barth³, D. Rubin⁴, M. Huisingh-Scheetz², M. Martinchek⁵, M. L. Madariaga³
Does Dialysis Modality or Duration Influence Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients?

M. Garner¹, B. Sharda², A. Farney³, J. Rogers², G. Orlando³, C. Jay⁴, A. Reeves-Daniel⁵, A. Mena-Gutierrez³, N. Sakhovskaya³, R. Stratta⁶
Does Donor-to-Recipient Weight Mismatch Influence Short Term Outcomes of Deceased Donor Kidney Transplantation?

L. Sabbagh, M. Killackey, H. Jeon, K. Atiemo, A. Paramesh, A. Vijay
Does Gene Mutation Carrier Status Contribute to Risk of Kidney Failure?

S. A. Muhsin, R. Saranu, B. Schreiber, E. Milford, M. Y. Yeung, A. Chandraker
Does Machine Perfusion of Heart for Donation After Cardiac Death (DCD) Transplantation Affect Other Organ Outcomes?

R. Misawa¹, K. Okumura², H. Sogawa¹, G. Veillette¹, A. Dhand³, R. Bodin⁴, D. C. Wolf⁴, B. Partiula⁴, D. John¹, T. Diflo⁵, S. Nishida¹
Does the New Kidney Transplant Allocation System Impact Delayed Graft Function Rates After Kidney Transplantation?

P. N. Chotai¹, F. Siddiqui², A. Logan³, K. Washburn⁴, A. Schenk⁵, A. Limkemann³
Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series

R. Pearson¹, J. Wubetu¹, K. Stevenson¹, E. Aitken¹, A. Jackson¹, M. Clancy², D. B. Kingsmore¹
Donor and Recipient Age Matching for Kidney Transplantation: A Machine Learning Approach

J. Kim, J. Ahn, A. Massie, D. Segev, S. Bae
Donor App Increases Awareness and Overall Rates of Living Kidney Donation

T. Shamaa¹, I. Bajjoka¹, H. Kandalaft¹, R. Prashar², M. Callaghan¹, C. Crombez¹, S. J. Serra¹, M. Abouljoud¹, J. Denny¹
Donor Black Race Modifies the Association Between Increasing Donor Age and Graft Failure Following Living Kidney Transplantation

K. Atiemo, R. Baudier, A. Anderson
Donor Derived Cell-Free DNA Median and Distribution in Pediatric Heart Transplant Patients

J. N. Gray¹, J. Miles¹, K. Oreschak¹, L. Jenkins¹, B. Feingold²
Donor Derived Transmissions 2020: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC) with a Focus on COVID-19

R. M. La Hoz¹, A. Agarwal¹, G. Berry¹, K. Dunn¹, J. Goldman¹, S. Ho¹, M. Kittleson¹, D. H. Lee¹, D. J. Levine¹, C. Marboe¹, G. Marklin¹, S. Pouch¹, R. Razonable¹, S. Taimur¹, H. Te¹, A. Woolley¹, C. Fox², C. Jett², S. Booker², D. K. Klassen², L. Danziger-Isakov¹
Donor Disposition AI Model to Predict Transplant for Recovered Deceased Donor Kidneys

L. Ashiku¹, R. Threlkeld¹, C. Dagli¹, M. Schnitzler², C. Canfield¹, K. Lentine², H. Randall²
Donor Exercise Preconditioning Protects Murine Orthotopic Liver Grafts During Ischemia Reperfusion Injury

H. O. Yazdani, C. Kaltenmeier, R. Nakano, R. L. Simmons, D. A. Geller, S. Tohme
Donor Factors Do Not Discriminate Living Donor Kidney Transplant Outcomes and Should Not Be Used to Promote the Use of Compatible Pairs in Kidney Paired Donation Programs

G. Irish¹, D. Chang², S. Chadban¹, N. Boudville¹, S. Campbell¹, J. Kanellis¹, L. McMichael², E. Sharples³, M. Kadatz², J. Gill², P. Clayton¹
Donor Genetic Background Predisposes Differentiation and Accumulation of Regulatory T Cells in the Kidney Allografts

X. Lai¹, J. Wang¹, S. Han¹, C. Chunlei¹, L. VanOsdol¹, L. Gallon², J. Leventhal², M. Kandpal¹, Z. Zhang¹
Donor Hospital Referrals of Potential Deceased Donors Slow Down on Weekends

A. L. Friedman, E. Marquez, H. Ghali
Donor Kidney-Resident Passenger Macrophages Promote CCL8-CCR8 Mediated Early Allograft Inflammation

A. Dangi¹, I. Husain², N. Natesh³, X. Shen³, J. Kwun⁴, X. Luo⁵
Donor Kidneys from Communities with Higher Deprivation Are Significantly More Likely to be Discarded

J. Schold¹, A. Huml¹, E. Poggio¹, E. Dewey¹, R. Buchalter¹, S. Husain², S. Mohan²
Donor Macrophage Depletion Improves Kidney Graft Function Despite Long Cold Ischemia

C. Jordan¹, A. Dangi², X. Luo¹
Donor Organ Utilization And Transplantation Outcomes In Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion

M. Urban, S. Merani, N. W. Markin, A. Castleberry, J. Um
Donor Terminal Creatinine – Does It Matter?

V. G. Menon, Y. Wert, W. Hoffman, D. Ladie, M. Singh, M. Waybill, H. Yang
Donor-Derived Carbapenem-Resistant Gram-Negative Infections: Risk Mitigation Strategy in Solid Organ Transplant Improves Recipients Safety and Could Expand Donor Pool

A. Mularoni¹, E. Graziano¹, M. Campanella¹, A. Cervo², M. Peghin³, F. Barbera¹, P. Conaldi¹, A. Luca¹, P. A. Grossi⁴
Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection

R. Gohh¹, J. Klein², M. Jagadeesan³, V. Rao⁴, M. Weir⁵, H. Gilligan⁶, G. Shekhtman⁷, N. Agrawal⁸, Y. Fu⁹, E. Akalin¹⁰
Donor-Derived Cell-Free DNA Across the Spectrum of Solid Organ Transplantation

S. R. Potter¹, J. Miles², K. Qu², R. Woodward², S. Dholakia²
Donor-Derived Cell-Free DNA and Gene Expression Profiling for Surveillance of Renal Allograft Injury and Rejection

A. N. Carrier, A. Crane, M. Pinedo, A. Bartosic, A. Haririan, J. R. Scalea, M. R. Weir, J. S. Bromberg
Donor-Derived Cell-Free DNA as a Biomarker of T Cell Mediated Rejection in Pediatric Kidney Transplant Patients

R. Dandamudi¹, S. Federman², R. Woodward², S. Dholakia², L. Walther¹, V. Dharnidharka¹
Donor-Derived Cell-Free DNA Testing in Kidney Transplantation: Do One-Month Values Have Any Prognostic Significance?

B. K. Sharda¹, M. Garner¹, A. Farney¹, G. Orlando², J. Rogers², C. Jay³, A. Daniel¹, A. Guiterrez¹, N. Sakhovskaya¹, R. Stratta¹
Donor-Derived Cell-Free DNA Trends Before and After Rejection Vary Based on Timing of Rejection

C. Rebello¹, K. Guo¹, S. Park², B. Kinsella¹, L. Zhao¹, J. Friedewald¹
Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft

D. Isaacson¹, J. Steggerda¹, Y. Xue¹, G. B. Auffenberg², N. N. Katariya³
Donor-Derived IL-33 Plays a Critical Role in Lung Allograft Acceptance

Y. Guo¹, Z. Mei¹, M. Khalil¹, D. Li¹, A. Banerjee¹, A. Gelman², D. Kreisel², A. Krupnick¹
Donor-Specific Hyporesponsiveness Following Kidney Transplantation is Explained by Progressive Loss of Donor-Reactive Polyfunctional Cd4+ Effector Memory T Cells

A. C. van der List, N. H. Litjens, M. Klepper, F. Prevoo, M. G. Betjes
Donor-Specific T Cell Senescence In Operationally Tolerant Liver Transplant Recipients

K. Deng¹, N. Tanimine², C. Breeden³, B. Burrell³, G. Gaile³, K. Lee¹, R. Matheson¹, F. Qiang¹, C. Rickert¹, C. LeGuern¹, J. Markmann¹
Donor-Specificb Cell Dysfunction and Suppressive Ability Are Differentially Induced in Cob-Mediated Transplantation Tolerance

S. Durgam¹, D. Yin¹, M. Alegre², A. Chong¹
Donor/Recipient Variabilities and Dd-cfdna Level

I. Gani¹, L. Mulloy¹, R. Mallavarapu¹, M. Saeed¹, R. Kapoor², A. Mirza¹
DonorNet Procurement Photos and Their Association with Kidney Utilization

M. Stuart¹, A. M. Placona¹, C. Martinez¹, K. Andreoni²
Donors’ Perceptions of Uterus Donation Motivations, Informed Consent and Value: A Qualitative Study of Dallas Uterus Transplant Study (duets) Participants

A. Wall¹, J. Hagen², V. Reddy³, E. Gordon⁴, L. Johannesson¹, G. Testa¹
Dual Deceased Donor Kidney Transplants: Maximizing Utilization of Suboptimal Kidneys

S. Nagaraju, S. Vaishnav, K. Boggs, T. Cook, A. Jones, J. B. Africa
Dual Therapy with Esculin and Erythropoietin Attenuates Renal Ischemia-Reperfusion Injury via P2x7 Receptor and Nlrp3 Inflammasome Inhibition, and Pi3k/akt Activation

E. Hafiz¹, W. H. El-Maadawy², M. Hassan³, M. H. Badawy⁴, S. Eldahshan⁴, A. AbuSeada⁵
Duration of Brain Death Does Not Impact Short Term Outcomes in Kidney Transplantation

A. M. Hawxby¹, R. Ketcham², J. P. Orlowski³, R. A. Squires², C. Hostetler²
Dynamic Changes and Roles of Specialized Pro-resolving Lipid Meditators in the Initiation and Resolution Process of Lung Ischemia-Reperfusion Injury in Rats

H. Oda¹, S. Tanaka¹, M. Shinohara², Y. Morimura¹, Y. Yokoyama¹, H. Kayawake¹, Y. Yamada¹, A. Ohsumi¹, D. Nakajima¹, H. Date¹
Dynamic Changes in Titer and Specificity Autoantibodies in Chronic Bm12 to B/6 Kidney Rejection

I. Sayin¹, D. Yin¹, D. Ghosh², M. Clark², A. Chong¹
Dynamic Changes of Serum Soluble B Cell Activating Factor in Kidney Transplant with De Novo Donor Specific Antibody

S. Wu¹, X. Su¹, Y. Gao¹, Y. Wei¹, Q. Ye¹, M. Huang², Y. Chen¹, J. Wang¹, Q. Zhang³, Q. Fu¹, J. Li², H. Huang², B. Xu², H. Zhang¹, L. Liu², C. Wang²
Dynamic Risk Prediction of Kidney Graft Failure After Deceased Donor Transplant

D. G. Hu¹, H. Thiessen Philbrook¹, S. Mohan², I. Hall³, M. Doshi⁴, K. F. Kerr⁵, C. R. Parikh¹
Dynapenia Among Kidney Transplant Candidates and Recipients in the United States

A. S. Nalatwad¹, X. Chen¹, N. M. Chu¹, S. P. Norman², D. L. Segev¹, M. McAdams-Demarco¹